全部分类
  • BP-1-102
    BP-1-102的可视化放大

    BP-1-102

    A STAT3 inhibitor

    此产品仅用于科学研究,我们不为任何个人用途提供产品和服务

    BP-1-102的二维码
    • 库存: 现货
    可选规格
    • 包装
      价格
      促销价
      数量
    • 2mg
      ¥487.00
      390.00
      - +
    • 5mg
      ¥762.00
      610.00
      - +
    • 10mg
      ¥1212.00
      970.00
      - +
    • 50mg
      ¥4850.00
      3880.00
      - +
    • 100mg
      ¥8012.00
      6410.00
      - +
    已选 0 0
    金额: ¥0.00
    首页 收藏
    • 货号: ajce52368
    • CAS: 1334493-07-0
    • 别名:
    • 分子式: C29H27F5N2O6S
    • 分子量: 626.59
    • 纯度: >98%
    • 溶解度: DMSO : ≥ 33 mg/mL (52.67 mM)
    • 储存: Store at -20°C
    • 库存: 现货

    Background

    BP-1-102 is an inhibitor of STAT3.1 It binds to STAT3 (Kd = 504 nM) and inhibits STAT3 binding to an IL-6R/gp130 peptide in a fluorescence polarization assay (IC50 = 4.1 ?M). BP-1-102 (10-30 ?M) decreases viability and proliferation of STAT3-dependent NIH3T3/v-Src, MDA-MB-231, PANC-1, DU145 and A549 cancer cells, but not STAT3-independent NIH3T3, NIH3T3/vRas, TE-71, and A2780S cancer cells. It reduces tumor growth and inhibits expression of the STAT3-dependent genes encoding c-Myc, survivin, Bcl-xL, cyclin D1, and VEGF in MDA-MB-231 and A549 mouse xenograft models when administered at doses of 1 and 3 mg/kg.


    1.Zhang, X., Yue, P., Page, B.D., et al.Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenograftsProc. Natl. Acad. Sci. USA109(24)9623-9628(2012)

    Protocol

    Cell experiment:

    Proliferating cells in 6- or 96-well plates are treated once with 0-30 μM BP-1-102 for 24 h or with 10 μM BP-1-102 for up to 96 h. Viable cells are counted by trypan blue exclusion/phase-contrast microscopy or assessed by a cell proliferation kit[1].

    Animal experiment:

    Mice: Athymic nude mice with established tumors are grouped and then given BP-1-102 (in 0.05% DMSO in water) at 1 or 3mg/kg (i.v.) every 2 or every 3 d or 3 mg/kg (oral gavage, 100 μL) every day for 15 or 20 d. Animals are monitored every day, and tumor sizes are measured with calipers and body weights are taken every 2 or 3 d. For each treatment group, the tumor volumes for each set of measurements are statistically analyzed in comparison with the control group using a paired T test[1].

    参考文献:

    [1]. Zhang X, et al. Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts. Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9623-8.
    [2]. De Simone V, et al. Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth. Oncogene. 2015 Jul;34(27):3493-503.

    此商品暂时还没有评价哦~

    温馨提示 ×
    商品已成功加入购物车!
    购物车共 0 件商品
    去购物车结算
    回到顶部